ENDRA Life Sciences (NASDAQ:NDRA) Announces Quarterly Earnings Results

ENDRA Life Sciences (NASDAQ:NDRA) posted its quarterly earnings data on Tuesday. The company reported ($3.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.23) by ($2.02), FiscalAI reports.

ENDRA Life Sciences Trading Down 0.6%

NASDAQ NDRA traded down $0.03 during mid-day trading on Tuesday, reaching $4.65. 15,329 shares of the company’s stock traded hands, compared to its average volume of 71,223. ENDRA Life Sciences has a 1-year low of $2.90 and a 1-year high of $11.96. The company has a fifty day simple moving average of $3.80 and a 200-day simple moving average of $4.86. The company has a market cap of $3.49 million, a price-to-earnings ratio of -0.18 and a beta of -0.08.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Ascendiant Capital Markets decreased their target price on shares of ENDRA Life Sciences from $38.00 to $30.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of ENDRA Life Sciences in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $30.00.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences, Inc (NASDAQ: NDRA) is a medical technology company headquartered in Ann Arbor, Michigan, that focuses on the development and commercialization of Thermoacoustic Enhanced Ultrasound (TAEUS™) imaging. The company’s proprietary TAEUS platform combines conventional ultrasound with thermoacoustic signals to provide non-invasive, real-time temperature monitoring of soft tissue. This technology is designed to improve the safety, efficacy and outcomes of thermal ablation procedures and other heat-based therapies.

ENDRA’s core product line centers on a compact, easy-to-integrate device that augments existing ultrasound systems.